CAD-1883

N/A

Report date: 2024/09/24 20:00:05
NME

Base Information

Drug NameCAD-1883
Drug Alias NameCAD-1883
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel agonists
TargetsPotassium channel
Therapy Area/IndicationsEssential TremorMachado-Joseph DiseaseSpinocerebellar Ataxias +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCadent Therapeutics IncSaniona A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCadent Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsEssential TremorMachado-Joseph DiseaseSpinocerebellar Ataxias +[4] 

Other Information

ATC CodeN/A
Related LinksN/A